Your Cart is Empty
Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.
GLP-1 is crucial for blood sugar control, boosting insulin release and supporting glucose balance. Lower GLP-1 levels can disrupt these processes, causing insulin resistance and elevated blood sugar. Taking a statin alongside a medication like Ozempic may diminish some of its intended effects, especially those related to managing blood sugar.
The study consisted of 30 participants, taking the drug atorvastatin. They were monitored for four months with various controls. While cholesterol levels dropped as anticipated, blood sugar slightly increased, insulin resistance worsened, and GLP-1 levels decreased by nearly 50%.
The study revealed that statins modify the gut microbiome, particularly reducing Clostridium bacteria, which produce UDCA, a bile acid that supports GLP-1 production. With reduced microbes, UDCA levels dropped, leading to lower GLP-1. Essentially, statins disrupted a gut microbial pathway critical for blood sugar regulation.
Many doctors prescribe statins without discussing their impact on insulin resistance or overall metabolic health. For patients managing cholesterol and blood sugar, this overlooked connection is vital.
Lifestyle interventions are indeed critical as a first-line approach to support and maintain metabolic health, especially for individuals on statins. Prioritizing lifestyle changes can enhance the effectiveness of statins, potentially reduce reliance on medication, and improve overall health.
To view the original scientific study click below:
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
While melanoma and squamous cell carcinoma are generally slow-growing and rare, a new study finds that people with tattoos face a greater risk of developing melanoma. While tattoos raised melanoma risk, they did not increase the odds of squamous cell carcinoma, another sun-driven skin cancer that, unlike the much more lethal melanoma, arises from different skin cells.
A groundbreaking new study reveals that soybean oil, the most consumed edible oil in the U.S., may directly drive obesity, independent of calorie intake. Scientists now have compelling evidence that the problem isn’t the oil itself. Instead, the real culprit appears to be the harmful metabolites soybean oil produces once inside the body.
New research shows that keeping your heart healthy might depend on what’s happening in your gut. Inside your digestive system live trillions of bacteria, viruses, and fungi, known as the gut microbiome, that influence far more than just digestion. These microscopic inhabitants play a surprisingly powerful role in protecting your heart and reducing the risk of cardiovascular disease.